These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16145314)
21. Comparison of tibolone and 17beta-estradiol administration on the expression of zonula occludens-1, occludin, glial fibrillary acidic protein and c-fos levels in the brain cortex and hippocampus of female rats. Ceylan U; Akhan SE; Bastu E; Gungor-Ugurlucan F; Iyibozkurt AC; Topuz S Neuro Endocrinol Lett; 2012; 33(5):505-10. PubMed ID: 23090268 [TBL] [Abstract][Full Text] [Related]
22. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer. Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769 [TBL] [Abstract][Full Text] [Related]
23. Effects of raloxifene on the urethra of adult castrated female rats. dos Santos AR; Lopes-Costa PV; Borges CS; Pires CG; de Sousa JM; de Castro JC; da Silva BB Climacteric; 2008; 11(6):483-8. PubMed ID: 18991075 [TBL] [Abstract][Full Text] [Related]
24. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium. Mirkin S; Archer DF Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063 [TBL] [Abstract][Full Text] [Related]
25. Effect of tibolone on turnover of cholesterol to bile acids in ovariectomized rats. Czerny B; Teister M; Juzyszyn Z; Mysliwiec Z; Pawlik A Menopause; 2005; 12(5):609-12. PubMed ID: 16145315 [TBL] [Abstract][Full Text] [Related]
26. Kinetic and morphometric responses of heterogeneous populations of experimental breast cancer cells in vivo. Lancaster S; English HF; Demers LM; Manni A Cancer Res; 1988 Jun; 48(11):3276-81. PubMed ID: 3365706 [TBL] [Abstract][Full Text] [Related]
27. Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation. Eilertsen AL; Qvigstad E; Andersen TO; Sandvik L; Sandset PM Maturitas; 2006 Oct; 55(3):278-87. PubMed ID: 16713143 [TBL] [Abstract][Full Text] [Related]
28. Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells? Sioulas VD; Politi E; Rizos D; Augoulea A; Kyroudi A; Sergentanis TN; Panoulis C; Aravantinos L; Creatsa M; Lambrinoudaki I Climacteric; 2012 Apr; 15(2):181-5. PubMed ID: 22066937 [TBL] [Abstract][Full Text] [Related]
29. Effects of estrogen and tibolone on bladder histology and estrogen receptors in rats. Yang X; Li YZ; Mao Z; Gu P; Shang M Chin Med J (Engl); 2009 Feb; 122(4):381-5. PubMed ID: 19302740 [TBL] [Abstract][Full Text] [Related]
30. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis). Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242 [TBL] [Abstract][Full Text] [Related]
31. Diabetes modulates differentially creatine kinase-specific activity responsiveness to estradiol-17beta and to raloxifene in rat organs. Somjen D; Shen M; Stern N; Mirsky N J Cell Biochem; 2006 Sep; 99(1):133-9. PubMed ID: 16598752 [TBL] [Abstract][Full Text] [Related]
32. In vivo properties of the urinary bladder wall and their modulation by estradiol and raloxifene in a rat model. Schultens A; Becker T; Balmer D; Seidlová-Wuttke D; Wuttke W Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):514-9. PubMed ID: 15505759 [TBL] [Abstract][Full Text] [Related]
33. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats. Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450 [TBL] [Abstract][Full Text] [Related]
34. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression. Ting AY; Kimler BF; Fabian CJ; Petroff BK Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317 [TBL] [Abstract][Full Text] [Related]
35. Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats. Wong CM; Yao X; Au CL; Tsang SY; Fung KP; Laher I; Vanhoutte PM; Huang Y Vascul Pharmacol; 2006 May; 44(5):290-8. PubMed ID: 16542882 [TBL] [Abstract][Full Text] [Related]
36. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France]. Jamin C; Bourg F; Legeai J; Senoussi S Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic effect of paclitaxel and propolis on lipid peroxidation and antioxidant system in 7,12 dimethyl benz(a)anthracene-induced breast cancer in female Sprague Dawley rats. Padmavathi R; Senthilnathan P; Chodon D; Sakthisekaran D Life Sci; 2006 May; 78(24):2820-5. PubMed ID: 16375927 [TBL] [Abstract][Full Text] [Related]
38. The growth-promoting action of individual women's sera on mammary carcinoma cells. Auer D; Hubalek M; Fleischer M; Roessler J; Daxenbichler G Anticancer Res; 2008; 28(4B):2213-7. PubMed ID: 18751397 [TBL] [Abstract][Full Text] [Related]
39. The potential antioxidant effect of raloxifene treatment: a study on heart, liver and brain cortex of ovariectomized female rats. Konyalioglu S; Durmaz G; Yalcin A Cell Biochem Funct; 2007; 25(3):259-66. PubMed ID: 16927419 [TBL] [Abstract][Full Text] [Related]
40. Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis. Pompei LM; Cunha EP; Steiner ML; Theodoro TR; Mader AM; Petri G; Pinhal MA; Fernandes CE Climacteric; 2015; 18(4):518-22. PubMed ID: 25830529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]